Tenofovir alafenamide (TAF) replaced tenofovir disoproxil fumarate (TDF) in HIV regimens. Which pharmacokinetic property explains TAF's lower renal and bone toxicity at 10-fold lower doses?

• A TAF bypasses the phosphorylation step required by TDF, enabling direct insertion into viral DNA without generating reactive phosphonate intermediates
• B TAF is stable in plasma and efficiently converted intracellularly within lymphocytes to tenofovir diphosphate by cathepsin A, resulting in higher intracellular drug levels in target cells with 90% lower plasma tenofovir concentrations, reducing proximal tubular and bone exposure ✓
• C TAF is effluxed by ABCC2 (MRP2) in the proximal tubule, preventing renal accumulation unlike TDF which is a substrate of ABCC4
• D TAF is a carboxylate ester of tenofovir that is hydrolyzed by alkaline phosphatase in bone, reducing its anabolic interference with osteoblast signalling

Explanation

Tenofovir disoproxil fumarate (TDF) is a prodrug that is rapidly converted in plasma to tenofovir by intestinal and blood esterases. High plasma tenofovir concentrations drive uptake by proximal renal tubular cells (via OAT1 and OAT3 transporters on the basolateral membrane) and accumulate in bone, causing Fanconi syndrome-like proximal tubular dysfunction and reduced bone mineral density at full doses. Tenofovir alafenamide (TAF) is a phosphonamidate prodrug designed to be stable in plasma (resistant to plasma esterases) and efficiently cleaved intracellularly by cathepsin A to generate tenofovir within lymphocytes and macrophages. This targeted intracellular activation yields tenofovir diphosphate (the active form) at much higher concentrations in CD4+ T cells, allowing TAF at 25 mg (vs TDF 300 mg) to achieve equivalent antiviral efficacy with ~90% lower plasma tenofovir — dramatically reducing proximal tubular and bone toxicity.

Reference: KD Tripathi, Essentials of Medical Pharmacology, 8th ed.

High-yield for: NEET PGINI-CETNExTFMGEUSMLEPLABMRCP

Written and medically reviewed by the StethoPrep medical team.